The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in......
The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now,......
The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron. IMAGE: A nurse prepares......
The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to......
Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......
Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......
The European Medicines Agency’s review is the second setback to Alkem Laboratories. Alkem Laboratories has been accused by Germany’s health regulator of fudging data on clinical trials......
IT majors Infosys and TCS were the top losers while capital goods shares BHEL and L&T ended firm on robust core sector growth. Despite a marginal recovery in late trades benchmark share indices......
Cipla stopped making the product last year; Abbott Laboratories and Pfizer have had to reduce batch sizes by up to half. Indian regulators are privately pressuring major drug firms to better police......